259
Views
32
CrossRef citations to date
0
Altmetric
Original Research

Nanosized functional miRNA liposomes and application in the treatment of TNBC by silencing Slug gene

, , , , , , , , , & show all
Pages 3645-3667 | Published online: 17 May 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Seyedeh Melika Ahmadi, Shervin Amirkhanloo, Rezvan Yazdian-Robati, Hossein Ebrahimi, Faezeh Hosseini Pirhayati, Waleed H. Almalki, Pedram Ebrahimnejad & Prashant Kesharwani. (2023) Recent advances in novel miRNA mediated approaches for targeting breast cancer. Journal of Drug Targeting 31:8, pages 777-793.
Read now

Articles from other publishers (31)

Apurva Jaiswal, Neha Kaushik, Eun Ha Choi & Nagendra Kumar Kaushik. (2023) Functional impact of non-coding RNAs in high-grade breast carcinoma: Moving from resistance to clinical applications: A comprehensive review. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:4, pages 188915.
Crossref
Sofia Torres Quintas, Ana Canha‐Borges, Maria José Oliveira, Bruno Sarmento & Flávia Castro. (2023) Special Issue: Nanotherapeutics in Women's Health Emerging Nanotechnologies for Triple‐Negative Breast Cancer Treatment. Small.
Crossref
Sonali S. Shinde, Sakeel Ahmed, Jonaid Ahmad Malik, Umme Hani, Afreen Khanam, Faisal Ashraf Bhat, Suhail Ahmad Mir, Mohammed Ghazwani, Shadma Wahab, Nazima Haider & Abdulrahman A. Almehizia. (2023) Therapeutic Delivery of Tumor Suppressor miRNAs for Breast Cancer Treatment. Biology 12:3, pages 467.
Crossref
Stefania Scialla, Mahmoud S. Hanafy, Jie-Liang Wang, Nuria Genicio, Milene Costa Da Silva, Marta Costa, Sofia Oliveira-Pinto, Fátima Baltazar, Juan Gallo, Zhengrong Cui & Manuel Bañobre-López. (2023) Targeted treatment of triple-negative-breast cancer through pH-triggered tumour associated macrophages using smart theranostic nanoformulations. International Journal of Pharmaceutics 632, pages 122575.
Crossref
Aiswarya Chaudhuri, Dulla Naveen Kumar, Rasheed A. Shaik, Basma G. Eid, Ashraf B. Abdel-Naim, Shadab Md, Aftab Ahmad & Ashish Kumar Agrawal. (2022) Lipid-Based Nanoparticles as a Pivotal Delivery Approach in Triple Negative Breast Cancer (TNBC) Therapy. International Journal of Molecular Sciences 23:17, pages 10068.
Crossref
Mina Zare, Rakesh Pemmada, Maya Madhavan, Aswathy Shailaja, Seeram Ramakrishna, Sumodan Padikkala Kandiyil, James M. Donahue & Vinoy Thomas. (2022) Encapsulation of miRNA and siRNA into Nanomaterials for Cancer Therapeutics. Pharmaceutics 14:8, pages 1620.
Crossref
Ioana Toma, Alina Silvia Porfire, Lucia Ruxandra Tefas, Ioana Berindan-Neagoe & Ioan Tomuță. (2022) A Quality by Design Approach in Pharmaceutical Development of Non-Viral Vectors with a Focus on miRNA. Pharmaceutics 14:7, pages 1482.
Crossref
Aiswarya Chaudhuri, Dulla Naveen Kumar, Deepa Dehari, Sanjay Singh, Pradeep Kumar, Pradeep Kumar Bolla, Dinesh Kumar & Ashish Kumar Agrawal. (2022) Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC). Pharmaceuticals 15:5, pages 542.
Crossref
Marcela Tavares Luiz, Jessyca Aparecida Paes Dutra, Larissa Bueno Tofani, Jennifer Thayanne Cavalcante de Araújo, Leonardo Delello Di Filippo, Juliana Maldonado Marchetti & Marlus Chorilli. (2022) Targeted Liposomes: A Nonviral Gene Delivery System for Cancer Therapy. Pharmaceutics 14:4, pages 821.
Crossref
Meshal Alshamrani. (2022) Broad-Spectrum Theranostics and Biomedical Application of Functionalized Nanomaterials. Polymers 14:6, pages 1221.
Crossref
Mst Shamima Khatun, Md Ashad Alam, Watshara Shoombuatong, Md Nurul Haque Mollah, Hiroyuki Kurata & Md Mehedi Hasan. (2022) Recent Development of Bioinformatics Tools for microRNA Target Prediction. Current Medicinal Chemistry 29:5, pages 865-880.
Crossref
Teresita Arredondo-Ochoa & Guillermo A. Silva-Martínez. (2022) Microemulsion Based Nanostructures for Drug Delivery. Frontiers in Nanotechnology 3.
Crossref
Natassa Pippa, Hector Katifelis, Maria Gazouli & Stergios Pispas. 2022. Applications of Nanovesicular Drug Delivery. Applications of Nanovesicular Drug Delivery 1 20 .
Srushti Tambe, Sabya Sachi Das, Neeru Singh, Priya Ranjan Prasad Verma, Purnima Amin & Sandeep Kumar Singh. 2022. Hormone Related Cancer Mechanistic and Nanomedicines. Hormone Related Cancer Mechanistic and Nanomedicines 219 238 .
Min Xia, Xuyu Zu, Zuyao Chen, Gebo Wen & Jing Zhong. (2021) Noncoding RNAs in triple negative breast cancer: Mechanisms for chemoresistance. Cancer Letters 523, pages 100-110.
Crossref
Francesca Maria Orlandella, Luigi Auletta, Adelaide Greco, Antonella Zannetti & Giuliana Salvatore. (2021) Preclinical Imaging Evaluation of miRNAs’ Delivery and Effects in Breast Cancer Mouse Models: A Systematic Review. Cancers 13:23, pages 6020.
Crossref
Huyi Liu, Xiangdao Cai, Jia Liu, Fengxiang Zhang, Andong He & Ruiman Li. (2021) The MEG3 lncRNA promotes trophoblastic cell growth and invasiveness in preeclampsia by acting as a sponge for miR-21, which regulates BMPR2 levels. European Journal of Histochemistry 65:4.
Crossref
Nagabhishek Sirpu Natesh, Brianna M. White, Maia M. C. Bennett, Metin Uz, Rakhee Rathnam Kalari Kandy, Surinder K. Batra, Surya K. Mallapragada & Satyanarayana Rachagani. (2021) Emerging Role of miR-345 and Its Effective Delivery as a Potential Therapeutic Candidate in Pancreatic Cancer and Other Cancers. Pharmaceutics 13:12, pages 1987.
Crossref
Mohammad Yahya Momin, Ravinder Reddy Gaddam, Madeline Kravitz, Anisha Gupta & Ajit Vikram. (2021) The Challenges and Opportunities in the Development of MicroRNA Therapeutics: A Multidisciplinary Viewpoint. Cells 10:11, pages 3097.
Crossref
Biyao Yang, Bo-ping Song, Shaina Shankar, Anna Guller & Wei Deng. (2021) Recent advances in liposome formulations for breast cancer therapeutics. Cellular and Molecular Life Sciences 78:13, pages 5225-5243.
Crossref
Anna Maria Grimaldi, Marco Salvatore & Mariarosaria Incoronato. (2021) miRNA-Based Therapeutics in Breast Cancer: A Systematic Review. Frontiers in Oncology 11.
Crossref
Xiaoyan Dai, Yanli Xin, Weizhi Xu, Xinxia Tian, Xiaofan Wei & Hongquan Zhang. (2020) CBP-mediated Slug acetylation stabilizes Slug and promotes EMT and migration of breast cancer cells. Science China Life Sciences 64:4, pages 563-574.
Crossref
Sukanya Ghosh & Manidipa Banerjee. (2021) A smart viral vector for targeted delivery of hydrophobic drugs. Scientific Reports 11:1.
Crossref
Mengwei Sun, Yuhao Yuan, Fake Lu & Anthony J. Di Pasqua. (2021) Physicochemical Factors That Influence the Biocompatibility of Cationic Liposomes and Their Ability to Deliver DNA to the Nuclei of Ovarian Cancer SK-OV-3 Cells. Materials 14:2, pages 416.
Crossref
Vijay Sagar Madamsetty, Anubhab Mukherjee & Manash K. Paul. 2021. Biogenic Nanoparticles for Cancer Theranostics. Biogenic Nanoparticles for Cancer Theranostics 189 228 .
Meriem Rezigue, Mohammad A. Obeid, Haneen Amawi & Alaa A.A. Aljabali. 2021. Handbook on Nanobiomaterials for Therapeutics and Diagnostic Applications. Handbook on Nanobiomaterials for Therapeutics and Diagnostic Applications 385 407 .
Jun Sheng Wong & Yoke Kqueen Cheah. (2020) Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer. Non-Coding RNA 6:3, pages 29.
Crossref
Zhiguang Yang & Zhaoyu Liu. (2020) The Emerging Role of MicroRNAs in Breast Cancer. Journal of Oncology 2020, pages 1-7.
Crossref
Dinglin Zhang & Jianxiang Zhang. (2020) Surface engineering of nanomaterials with phospholipid-polyethylene glycol-derived functional conjugates for molecular imaging and targeted therapy. Biomaterials 230, pages 119646.
Crossref
Dennis Gerloff, Cord Sunderkötter & Johannes Wohlrab. (2020) Importance of microRNAs in Skin Oncogenesis and Their Suitability as Agents and Targets for Topical Therapy. Skin Pharmacology and Physiology 33:5, pages 270-279.
Crossref
Sruti Bheri & Michael E. Davis. (2019) Nanoparticle–Hydrogel System for Post-myocardial Infarction Delivery of MicroRNA. ACS Nano 13:9, pages 9702-9706.
Crossref